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Abstract
Background: In Burkina Faso, very little is known about the quality of life of persons living with HIV through their
routine follow- up. This study aimed to assess the quality of life of persons living with HIV, and its change over a
1-year period.
Methods: Four hundred and twenty four (424) persons living with HIV were monitored during twelve (12) months
from September 2012 to September 2013 in Ouagadougou, the capital city of Burkina Faso. Three interviews were
conducted in order to assess the quality of life of patients and its change over time, using the World Health
Organization Quality of Life assessment brief scale in patients with Human Immunodeficiency Virus infection
(WHOQOL HIV-BREF). The Friedman test was used to assess significant differences in quantitative variables at each
of the three follow-up interviews. Groups at baseline, at 6 months and at 12 months were compared using
Wilcoxon signed rank test for quantitative data and McNemar test for qualitative variables. Pearson Chi2 was used
when needed. Multivariable logistic regression models were fit to estimate adjusted odds ratio (OR) and 95 %
confidence intervals (95 % CI). Trends in global quality of life score and subgroups (status related to Highly Active
Anti Retroviral Treatment (HAART) using univariate repeated measures analysis of variance were assessed. A p-value
less than 0.05 was considered significant.
Results: At baseline, quality of life scores were highest in the domain of spirituality, religion and personal beliefs
(SRPB) and lowest in the environmental domain. This trend was maintained during the 12-month follow-up. The
global score increased significantly from the beginning up to the twelfth month of follow-up. Over the 12 months,
the baseline factors that were likely to predict an increase in the global quality of life score were: not having
support from relatives for medical care (P = 0.04), being under HAART (P = 0.001), being self-perceived as healthy
(P = 0.03), and having a global quality of life score under 77 (P < 0.001).
Conclusions: Our findings suggest the need to promote interventions to empower people living with HIV/AIDS
through income generating activities. Such activities will enhance the quality of life of persons living with HIV in
Burkina Faso. This could focus mostly on treatment-naïve HIV patients, lacking support from relatives and those
who perceive themselves as ill.
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Background
Epidemiological studies have shown that early treatment
of persons living with HIV/AIDS (PLWHA) using
Highly Active Anti-Retroviral Treatment (HAART) sub-
stantially reduces their risk of transmitting the virus
and/or developing HIV-related illness [1, 2]. HAART
has also proven its efficacy in PLWHA by decreasing
HIV-associated mortality and morbidity rates [3]. Given
the improved life-expectancy of people living with HIV,
there is a need to assess their quality of life on a long
term basis. In Burkina Faso, UNAIDS reported in 2012 a
seroprevalence of 1.1 % in the general population [4].
The same year, 45000 PLWHA were under HAART,
which accounted for 45 % of the total estimated number
of PLWHA in need of treatment [4]. A previous cross
sectional study on the quality of life of PLWHA, with or
without treatment, showed that treated individuals were
likely to have a better quality of life compared to treat-
ment naïve-infected subjects in Burkina Faso [5]. Another
longitudinal study which assessed the quality of life of per-
sons initiating the treatment showed the trends of their
quality of life over a 12-month period [6]. However, very
little is known about the trend of the quality of life over
time in untreated PLWHA compared to treated patients.
Exploring quality of life trends in treated and untreated
patients will help the health care system develop adapted
strategies to better manage the PLWHA in low-income
countries.
This study aimed to assess the quality of life of persons
living with HIV in Burkina Faso, in their routine follow-
up and its change over time.
Methods
A longitudinal study was conducted from September
2012 to September 2013, in Ouagadougou, capital city of
Burkina Faso, in the following five healthcare facilities,
chosen for the high number of PLWHA under their
care: two (2) public healthcare facilities (under the na-
tional healthcare system) and three (3) community-based
healthcare organizations. The public healthcare facilities
were as follows: the District Hospital of Boulmiougou
(DHB) and the University Hospital Yalgado Ouédraogo
(UHYO, Day Hospital Unit). The community-based orga-
nizations were as follows: the Center for Information,
Counseling and Documentation on AIDS and Tubercu-
losis (CICDoc), the Association African Solidarity (AAS),
and the Association Laafi la Viim (ALAVI). The PLWHA
followed up by these five (5) facilities accounted for
35.03 % of the cohort followed up nationwide.
Based on a 95 % confidence level, assuming that 50 % of
PLWHA should experience an increase in their quality of
life during the 12-month follow-up, with 5 % precision,
the required sample size was 385. In order to account for
the possibility of patients who will not attend the follow-
up interviews, this sample size was increased by 10 %, giv-
ing a total sample size rounded up to 424 PLWHA. The
number of interviewees per structure was determined ac-
cording to the size of the structure. The numbers were
150, 135, 64, 39 and 36, respectively for the DHB, the Day
Hospital Unit, the CICDoc, the AAS and the ALAVI. In
each facility, recruitment was done through the daily rou-
tine check-up, using a systematic sampling technique. Se-
lected patients were then followed for 12 months. To
assess the quality of life, the World Health Organization’s
Quality of Life HIV brief scale [WHOQOL HIV- BREF]
[7], the short version of the World Health Organization’s
Quality of Life HIV [WHOQOL HIV] [8] was used. The
following reasons justified the choice of this scale: 1) the
scale is specific to PLWHA; 2) by its length (31 questions),
the WHOQOL HIV-BREF is well suited for investigation
and for routine consultation; 3) French is the official lan-
guage in Burkina Faso and there is a validated French ver-
sion of the WHOQOL HIV-BREF [9]; 4) Moore is the
national language spoken by the majority of Burkinabe
[10], and a Moore version of WHOQOL HIV-BREF with
good psychometric properties is available [11]; and 5) un-
like most quality of life assessment scales, which are usu-
ally developed in the western world, the WHOQOL HIV
and its short version were developed in centers around
the world, including two centers in Africa, making them
cross-culturally sensitive [12]. The reliability of the scale
used in our study was assessed through the internal
consistency using the Cronbach’s alpha.
The WHOQOL HIV- BREF is a scale with 31 ques-
tions asking the respondent to assess his/her own quality
of life in various ways during the 2 weeks preceding the
survey. It explores six domains of the quality of life
(physical, psychological, level of independence, social re-
lationships, environment and spirituality, religion, and
personal beliefs (SRPB)). Each domain explores a certain
number of facets of daily life. The physical domain refers
to pain and discomfort, energy and fatigue, sleep and
rest, as well as symptoms of HIV. The psychological do-
main includes positive feelings thinking, learning memory
and concentration, self-esteem, body image and appear-
ance, and negative feelings. As for the level of independ-
ence domain, it explores mobility, activities of daily living,
dependence on medication or treatments, and work cap-
acity. The social relationships domain covers personal re-
lationships, social support, sexual activity and social
inclusion. The environment domain refers to physical
safety and security, home environment, financial re-
sources, health and social care (accessibility and quality),
opportunities for acquiring new information and skills,
participation in and opportunities for recreation/leisure
activities, physical environment (pollution, noise, traffic,
climate), and transport. Finally, the spirituality, religion
and personal beliefs domain includes spirituality, religion
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and personal beliefs, forgiveness and blame; concerns
about the future; as well as death and dying.
Answers to the questions were rated on a Likert scale
from 1 (very negative) to 5 (very positive). Twenty-nine
questions were used to construct a score per domain
and an global quality of life score. The score of a specific
domain was obtained by multiplying the average score of
the domain by 4, leading to scores ranging from 4 to 20.
One question explores quality of life in general and an-
other one explores general health. The global quality of
life score is obtained by summing scores of domains,
leading to scores ranging from 24 to 120. Higher scores
indicate better quality of life in the domain or better
quality of life overall.
Data were collected through 3 interviews by well-
trained interviewers. The first interview was conducted
at the beginning of the study; the second was conducted
at 6 months and the third was conducted at 12 months
after the baseline interview. All the 424 PLWHA an-
swered the questionnaire at the first interview. Only 384
answered at the second interview and 351 answered at
the third interview. Among people who did not answer
the third interview, one refused to continue the study at
the second interview and two died. Eleven patients who
had not attended the second interview came to the third.
These 11 were excluded from matched analyses.
Analyses were performed using IBM SPSS 21.0. The
Friedman test was used to assess significant differences
in quantitative variables at each of the three follow-up
interviews. Groups at baseline, at 6 months and at
12 months were compared using Wilcoxon signed rank
test for quantitative data and McNemar test for quali-
tative variables. Pearson Chi2 was used when needed.
Multivariable logistic regression models were fit to es-
timate adjusted odds ratio (OR) and 95 % confidence
intervals (95 % CI). A p-value less than 0.05 was con-
sidered significant. We assessed trends in the global
quality of life score and subgroups (status related to
HAART) using univariate repeated measures analysis
of variance. The present study was approved by the
Ethics Committee for Health Research from the Ministry
of Health of Burkina Faso. All participants who were
contacted agreed to participate in the study and
signed a free and informed consent.
Results
Four hundred and twenty four (424) individuals agreed to
participate in the study. At baseline, 12.5 % were male.
67.2 and 32.8 % of participants were respectively recruited
in public healthcare facilities and community-based
facilities. Over 40 % (44.8 %) of patients were living
with another person and 27.1 % were treatment-naive
HIV subjects. Fewer than 70 % (67.9 %) of patients
had undergone treatment for at least 1 year. The mean
duration under treatment was 5 ± 3.1 years. Approxi-
mately 1/3 of the respondents did not attend school. Just
over half of the patients (50.7 %) worked in small trading
or in the informal sector. Over 80 % (81.4 %) of the re-
spondents had shared their HIV status with a family
member.
Out of the 424 people at baseline, 351 took part in the
last interview (month 12). When comparing the charac-
teristics of respondents who participated in the last
interview and those who did not, we did not find signifi-
cant differences, apart from HAART status. Neverthe-
less, the proportion of respondents not yet under
HAART, who participated in the third interview, was
lower (23.8 %) than the proportion of the respondents
not yet under HAART who did not participate in the
third interview (37 %) (Table 1).
The assessment of the reliability of the whole scale at
baseline gave a Cronbach’s alpha set at 0.85. At baseline,
the highest scores of quality of life were recorded in the
domain of spirituality, religion and personal beliefs
(SRPB) and the lowest scores were in the environment do-
main. This trend was maintained during the 12-month
follow-up (Figs. 1 & 2).
From the beginning of the follow-up to the sixth
month, four domains increased significantly (Table 2):
the psychological domain (+0.7), level of independence
(+2.2), social relationships (+1.4) and the environmental
domain (+2.6). The global quality of life score also sig-
nificantly increased from baseline to month 6 (from
82.9 ± 10.9 to 84.6 ± 10.2). When comparing the domain
scores from baseline to the twelfth month of the follow-
up, the following domains showed significant progress:
the psychological domain (+0.8), level of independence
(+1), social relationships (+1.2) and the environmental
domain (+2.1). The global score not only increased
significantly from baseline to the twelfth month (from
82.9 ± 10.9 to 87.0 ± 9.1), but also from the sixth month to
the twelfth month (from 84.6 ± 10.2 to 87.0 ± 9.1).
Regarding HAART status, consistently high global
quality of life score in patients under treatment for at
least 1 year was observed (Fig. 3); they started with the
best scores (83.6) and they ended the follow-up with the
best scores (89.2). Those not yet under treatment
showed a trend of a consistently low global quality of life
score in the 12-month follow-up; they started with the
second best scores (81.3) and they ended the follow-up
with the worst scores (80.4). As for patients under treat-
ment for less than 3 months at baseline, their global
quality of life score leapt between recruitment and the
sixth month of the follow-up (from 80.9 to 86.5) before
stabilizing (86.1 at the end of the follow-up). Starting
with the lowest score (80.9), patients under treatment
for less than 3 months at baseline ended the follow-up
with the second best scores (86.1), while those not under
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treatment started with the second best scores (81.3) and
ended with the worst scores (80.4).
When considering the global quality of life score ac-
cording to PLWHA characteristics, significant increases
were recorded, except in men and people with an AIDS
status. In people not yet under treatment, a decreased,
yet non-significant, of global quality of life score was
recorded (Table 3). Using univariate repeated measures
analysis of variance, a linear trend was observed over
time and the HAART status significantly affected the
global quality of life score over time (F = 8.04; p < 0.001).
In a logistic regression, a global quality of life score >77
was strongly associated with a lesser increase over time
(OR:0.06 95 % CI [0.02–0.16]; P < 0.001). Although not
statistically significant, the longer a patient stayed under
HAART, the more he/she experienced an increase of his/
her global quality of life score. Having no support from
relatives for medical care at baseline was significantly as-
sociated with an increase in the global quality of life score
over time. In addition, being under HAART was associ-
ated with an increased global quality of life score
(OR:3.08, 95 % CI [1.59–5.96];P = 0.001). Finally, self per-
ception as healthy was also associated with an increased
global quality of life score over time (Table 4).
Discussion
At baseline, the highest scores were recorded in the do-
main of spirituality, religion and personal beliefs (SRPB)
and the lowest scores were seen in the environmental
domain. The environmental domain includes aspects re-
lated to the home environment, financial resources, acces-
sibility to health and social care, physical environment and
recreational activities. Burkina Faso is a country where
46.5 % of people live below the national poverty line [10].
The socio-economic profile of the country and the profes-
sional profile of our respondents dominated by the infor-
mal sector and small business could justify those low
scores recorded in the environmental domain. In previous
studies, similar results with lowest scores in environmen-
tal domain and highest scores in SRPB domain were also
found in Burkina Faso [5] and in Ethiopia [13, 14]. At the
third interview, the lowest and highest scores remained
respectively in the environmental domain and in the spir-
itual domain. These results are consistent with what was
found at baseline. Over the 12 months, the fact that the
religious practices of the respondents and their environ-
ments did not change could justify the sameness of scores
in these domains of quality of life. Other previous
longitudinal studies have shown the same trends. In a
study looking at HIV-Tuberculosis co-infected patients,
the spirituality domain showed the highest scores and the
environmental domain held the lowest scores after a 6-
month follow-up [14]. In the same study, patients with
HIV but not co-infected with tuberculosis showed the
same trends at the end of the 6 month follow-up.
In our study, four domains of quality of life showed pro-
gression at month 6 and at month 12 when comparing to
baseline. These domains were the psychological domain,
level of independence, social relationships and the envir-
onmental domain. These increased scores could be partly
explained by the support that PLWHA benefited from in
Table 1 Baseline characteristics of the participants of the all








interview (n = 73a)
P-value
Mean ± SD Mean ± SD
% %


















Public, private employee 16.2 15.1









Under treatment 76.2 63.0
No treatment 23.8 37.0
Sexual behavior 0.36
Risky 38.5 44.3
No risk 61.5 55.7
aTotal may differ according to characteristics
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Fig. 1 Cumulative frequency polygon of quality of life domain scores at baseline. *SRPB: Spirituality, Religion and Personal Believes
Fig. 2 Cumulative frequency polygon of quality of life domain scores at month 12. *SRPB: Spirituality, Religion and Personal Believes
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the HIV-care facilities, where our investigation was con-
ducted. These facilities offer, among others, support
groups such as psychological and social support, where
PLWHA come together and support one another in deal-
ing with their HIV status [15, 16]. Even if the environmen-
tal domain recorded increased scores, it remained, over
time, the domain with the lowest scores. In our study, the
physical domain, the religion, spirituality and personal be-
liefs domain, showed a sawtooth pattern. Deribew et al.,
on the other hand, showed a significant increase in all do-
mains of quality of life after a 6 month follow-up of
PLWHA initiating HAART [14]. According to HAART
status, our respondents under treatment for at least 1 year
showed a steadily rising global quality of life score over
12 months. In patients who started treatment at the begin-
ning of our study, the global quality of life score, after
undergoing a jump in the sixth month, showed a relative
decline, subsequently leading to stabilization. This trend
can be explained by the national context and the issues
PLWHA are facing. Usually, people in need of treatment
in Burkina Faso wait a long time before treatment be-
comes available, due to financial limits. Starting treatment
appears to be a solace for them. This situation, in addition
to the physiological benefits of HAART, can justify the
leap made in the sixth month in HIV patients who started
the treatment at the beginning of the study. In their longi-
tudinal study, Solomon et al. showed how quality of life
increased, even if the increase diminished with time, with
best increase which occurred between baseline and the
sixth month of their 12-month follow-up [17].
Our study showed that being under HAART was asso-
ciated with an increased global quality of life score. In
addition, the longer a patient stayed under HAART, the
more he/she experienced an increase of his/her global
quality of life score. The fact that people under HAART
experienced a greater increase in their global score is
consistent with what was found by Liu et al. [18]. Their
study showed that HAART was associated with a short
term (6 month) improvement in the summary score of
quality of life using the Medical Outcome Study (MOS)-
HIV. But, they also showed that there was no evidence
that HAART modifies trends in a long term follow-up.
Table 2 Changes in quality of life’s domains scores over
12 months in persons living with HIV in Burkina Faso (n = 340)






mean ± SD mean ± SD mean ± SD
Physical 14.9 ± 2.7 13.1 ± 2.6a 14.8 ± 3.0b
Psychological 13.7 ± 2.7 14.4 ± 2.5a 14.5 ± 2.0a
Level of independence 13.4 ± 2.5 15.6 ± 3.2a 14.4 ± 2.7b a
Social relationships 13.5 ± 2.8 14.9 ± 3.5a 14.7 ± 2.8a
Environmental 11.0 ± 2.2 13.6 ± 2.7a 13.1 ± 1.9b a
Spirituality 16.3 ± 2.6 13.3 ± 3.1a 15.2 ± 3.5b a
Global score of quality of life 82.9 ± 10.9 84.6 ± 10.2a 87.0 ± 9.1b a
aCompared with scores at baseline, Wilcoxon test (p < 0.05)
bCompared with scores at Month 6, Wilcoxon test (p < 0.05)
Fig. 3 Trends of global score of quality of life over 12 months by treatment group. *HAART: Highly Active Anti Retroviral Treatment
Bakiono et al. BMC Public Health  (2015) 15:1119 Page 6 of 10
Although not statistically significant, better increase
was observed in women. In line with gender, Jaquet et
al. in their study in Burkina Faso, showed that an in-
crease in Mental Health Status score was significant in
women and not in men [6].
In our study, having no support from relatives for
medical care was associated with an increase in the glo-
bal quality of life score. Because HIV is still considered
as a family shame, living with HIV puts people on the
margins of society or their family. In a previous study in
Burkina Faso, Ouedraogo et al. showed that 57.5 % of
PLWHA were living without any financial support from
families [19]. All facilities where our follow-up was
conducted offer the following services to PLWHA: an-
onymous voluntary counseling and testing (VCT), pre-
vention counseling, medical treatment and monitoring,
nutrition counseling, psychological and social support.
Among other specific services offered, there is also
medication, medical care for opportunist infections,
home visits, support groups, and food. These specific ac-
tivities undertaken by professionals or by peer educators
provide those with no family support with another op-
tion. The support received from the facilities can explain
why, despite having no support from relatives for med-
ical care, the global quality of life score grew, even if it
stayed lower than the global score of those who have
support from families for their medical care. Psycho-
logical support received from HIV facilities may explain
the association between self perception as healthy and
increased global quality of life score.
In a large study involving four southern African coun-
tries, people with lower education reported higher scores of
satisfaction with life [20]. Such a result is in line with our
study, where illiterate people recorded better proportion
with increased score, although not statistically significant.
Studies on the quality of life of persons living with
HIV in developing settings have shown the association
between, on one hand, the quality of life and, on the
other, biological tests, in particular viral load and CD4
cell count [21–23]. In our study, it was not possible to
analyze such association because very few patients have
updated biological data in their routine follow-up. We
assessed quality of life of persons living with HIV in
their routine life, which is the daily experience of these
people in HIV clinics. Even if the Government of Bur-
kina Faso declared free HAART for those in need since
January 1, 2010, PLWHA continue to face problems for
getting blood work done (viral load and CD4 count),
which are key to monitor the health. While biological
monitoring certainly allows for better medical follow-up,
it is out of reach for our patients because of the high
cost. Some patients manage to do their tests through
studies which pay for patients’ laboratory tests. Unfortu-
nately, at the end of such studies, they are faced once
again with the cost and discontinued tests. Once re-
search goals are achieved in the context of HIV/AIDS,
patients’ medical care is sometimes thwarted by sudden
costs. According to national guidelines, these tests have
to be done on a 6-month basis [24, 25]. Recent findings
showed that annual monitoring of CD4 instead of every
6 months in persons with a CD4 above 250 cells/mm3 was
sufficient to detect any clinical problem early enough [26].
Such results, associated with the fact that new guidelines
suggest starting HAART when CD4 reaches 500 cells/
mm3 [1], instead of previously indicated levels of 250 or
350 cells/mm3, will probably reduce the frequency of CD4
tests in PLWHA in their routine follow-up. As a result,
Table 3 The global score of quality of life at baseline and at
month 12: comparison based on the characteristics of persons
living with HIV in Ouagadougou, Burkina Faso





life at Month 12
p-valuea
Mean ± SD Mean ± SD
Gender
Male (n = 44) 87.4 ± 9.4 88.3 ± 10.8 0.66
Female (n = 307) 82.2 ± 10.8 87.1 ± 8.9 <0.001
HAART started
Before 2005 (n = 52) 82.4 ± 10.4 90.4 ± 6.9 <0.001
2005 and later (n = 209) 83.7 ± 11.0 88.9 ± 7.9 <0.001
Education
No school (n = 113) 79.6 ± 10.3 86.0 ± 9.5 <0.001
School (n = 238) 84.4 ± 10.6 87.8 ± 8.9 <0.001
Self perceived as healthy
No (n = 204) 85.4 ± 9.6 87.6 ± 8.3 0.021
Yes (n = 115) 78.7 ± 11.3 86.5 ± 10.0 <0.001
Serology status
Asymptomatic (n = 268) 84.0 ± 10.3 87.3 ± 10.3 0.02
Symptomatic (n = 63) 80.0 ± 10.8 87.7 ± 9.0 <0.001
AIDS (n = 14) 80.5 ± 12.0 83.7 ± 7.9 0.38
HIV services provider
Hospital (n = 235) 82.8 ± 10.4 88.0 ± 9.3 <0.001
Community based (n= 116) 82.9 ± 11.4 85.5 ± 8.6 0.03
Marital status
Alone (n = 194) 82.2 ± 11.1 86.6 ± 9.2 <0.001
In couple (n = 157) 83.7 ± 10.3 88.0 ± 9.0 0.001
HAART status
No treatment (n = 83) 82.0 ± 9.8 81.4 ± 10.7 0.62
Under treatment (n = 266) 83.2 ± 11.0 89.1 ± 7.8 <0.001
Sexual behavior risk
No risk (n = 214) 83.1 ± 10.9 87.4 ± 9.4 <0.001
Risk (n = 134) 82.6 ± 10.6 86.8 ± 8.7 <0.001
aWilcoxon test used
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significant cost savings may be made by PLWHA, giving
them more opportunity to do this key test.
In our study, about 17 % of patients were lost to
follow-up. Most of them were not under HAART. This
can be explained by the fact that when people are not
under treatment in a facility, they tend to leave that fa-
cility and look for another one in which they can find
treatment. Such patients, considered as lost to follow-up
in our sample, are probably in other facilities, except for
two of them who were known to have died during the
follow-up and one who openly refused to continue the
study. The proportion of patients lost to follow-up was
lower than what was recorded by Solomon et al. in their
study, with 61.8 % of lost to follow-up [17].
The internal consistency of the scale used in our study
gave a Cronbach’s alpha set at 0.85. This value is higher
than values usually recommended (ranging from 0.7 to 0.8)
[27, 28], which means our scale has good reliability.
In a study conducted in South Africa using the same
scale we used, the Cronbach’ alpha found was 0.88,
which is near to ours [29].
According to the latest data in the general population,
the prevalence of HIV is not statistically different by
gender (1.2 % in women and 0.8 % in men from 15 to
49 years old) [30]. Our study was comprised of 87.5 %
women. According to the data from the Ministry of
Health, people living with HIV attending HIV facilities
in the country were 69.7 % women [31]. In a previous
study in Burkina Faso, a high proportion (72 %), but
lower than ours, was recorded, even when the preva-
lence of HIV was higher in men than in women [32].
The proportion of women in our study is therefore
partly explained by the profile of PLWHA attending
HIV structures of the city, dominated by women.
Limitations
Our study was conducted in Ouagadougou, which is not
representative of the whole country. However, the facilities
where the study was conducted may be a good portrayal
of the urban reality of the country. Our sample was based
on a systematic sampling method, using the daily queue
for routine follow-up in each facility. The number of
Table 4 Factors associated with an increase of the global score of quality of life over 12 months in PLWHA in Ouagadougou,
Burkina Faso








ORna n (%) OR (95 % CI) OR (95 % CI)
Gender
Man 42 21(50.0) 1
Woman 298 193(64.8) 1.83(0.96–3.52)
Support for medical care
No 134 92(68.7) 1 1
Yes 205 121(59.0) 0.65(0.41–1.04) 0.56(0.32–0.97) 0.04
Highly Active Antiretroviral Treatment status
No 80 39(48.8) 1 1
Yes 258 174(67.4) 2.17(1.30–3.62) 3.08(1.59–5.96) 0.001
School
No 112 79(70.5) 1
Yes 228 135(59.2) 0.60(0.37–0.98)
Self perceived as healthy
No 198 111(56.1) 1 1
Yes 110 80(72.7) 2.09(1.26–3.46) 1.90(1.05–3.43) 0.03
Global score of QOL at baseline
< =77 90 84(93.3) 1 1
>77 250 130(52.0) 0.07(0.03–0.18) 0.06(0.02–0.16) <0.001
Treatment group at baseline
No Treatment 80 40(50.0) 1
Less than 3 months 19 12(63.2) 1.71(0.61–4.80)
1 year or more 241 162(67.2) 2.05(1.22–3.42)
aTotal may differ accordingly
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interviewees per structure was reached after a 1-month en-
rolment period. Given enrolment was over such a short
period, our sample may not be representative of patients in
the HIV facilities of the city all year round. Moreover, the
proportion of women in our sample, which was higher
than what had been found elsewhere in other studies, can
limit the representativeness of our sample. Our study did
not use biological tests. Nevertheless, an intervention with
biological follow-up based on laboratory tests could have
been useful for the relationship between quality of life,
items such as CD4 count and viral load, and clinical status.
Conclusions
Our findings suggest conducting interventions linked to
the environmental domain to enhance the quality of life
of persons living with HIV/AIDS in Burkina Faso. Such
interventions should be directed towards empowering
persons living with HIV instead of making them
dependent on ad hoc support. Particular attention could
be paid to women, illiterate people, people who perceive
themselves as ill, symptomatic patients and those not yet
under treatment. A pilot initiative to make affordable
loans available to PLWHA to enable them to start in-
come generating activities was initiated by the Support
Programme to Associative and Community World
(PAMAC) in Burkina Faso [33]. This operation, with a
98 % repayment rate, has enabled 783 persons living
with HIV to have access to these micro credits. The re-
sults showed that these people thrived and found a bet-
ter position in society. They thus manage to provide for
their households (health expenses, food, schooling for
children, etc.), but are also able to participate in the
management of social and family events (weddings,
baptisms, funerals, etc.), which constitutes a mark of
social integration. Another pilot project through small
home gardening or collective gardening initiated in
Ouagadougou showed how food needs of PLWHA
where met with products of these gardens. The surplus of
production was then sold to the population and profits of
the sale were used to meet other needs of PLWHA.
Extending these two initiatives to a larger number of
PLWHA in rural and urban areas will help them meet
their basic needs, improve their life and health-related
quality of life, and will contribute to job creation. How-
ever, such initiatives need to be undertaken through
community-based associations fighting against HIV/AIDS
for good guidance and a good monitoring.
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